SAGE

Sage Therapeutics
SAGE

Overview Fund Activity
Delisted

SAGE was delisted on the 30th of July, 2025.

Back to rankings

255 hedge funds and large institutions have $2.88B invested in Sage Therapeutics in 2021 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 100 increasing their positions, 73 reducing their positions, and 46 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
255
Holders Change
-6
Holders Change %
-2.3%
% of All Funds
4.45%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.09%
New
41
Increased
100
Reduced
73
Closed
46
Calls
$58.6M
Puts
$125M
Net Calls
-$66.5M
Net Calls Change
-$19M

Top Buyers

1
Wellington Management Group
1
Wellington Management Group
Massachusetts
$330M
2
Citadel Advisors
2
Citadel Advisors
Florida
$36.7M
3
BG
3
Bellevue Group
Switzerland
$134M
4
DKCM
4
Davidson Kempner Capital Management
New York
$43.3M
5
AG
5
Artal Group
Luxembourg
$56.8M

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$390M
2
Invesco
2
Invesco
Georgia
$31.6M
3
AllianceBernstein
3
AllianceBernstein
Tennessee
$1.29M
4
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$89.3M
5
Victory Capital Management
5
Victory Capital Management
Texas
$387K
Name Holding Trade Value Shares
Change 		Shares
Change %
FHA
251
First Horizon Advisors
Tennessee
$1K +$474 +9 +90%
SIM
252
Sonora Investment Management
Arizona
$1K +$1K +16 New
WIM
253
Westside Investment Management
California
$150 – – –
Nisa Investment Advisors
254
Nisa Investment Advisors
Missouri
$116 -$51 -900 -31%
AIG
255
American International Group
New York
$36 -$1 -10 -2%
FCM
256
Farallon Capital Management
California
– -$25.8M -345,000 Closed
WP
257
Woodline Partners
California
– -$17.5M -234,434 Closed
Two Sigma Investments
258
Two Sigma Investments
New York
– -$11.3M -150,794 Closed
IC
259
Ikarian Capital
Texas
– -$6.82M -91,151 Closed
ACM
260
Asymmetry Capital Management
California
– -$5.96M -79,650 Closed
SFI
261
Susquehanna Fundamental Investments
Pennsylvania
– -$2.82M -37,626 Closed
GTC
262
Ghost Tree Capital
New York
– -$2.25M -30,000 Closed
IBT
263
International Biotechnology Trust
United Kingdom
– -$1.61M -21,500 Closed
Thrivent Financial for Lutherans
264
Thrivent Financial for Lutherans
Minnesota
– -$1.49M -19,883 Closed
CII
265
Capital International Inc
California
– -$1.31M -17,429 Closed
Aviva
266
Aviva
United Kingdom
– -$1.26M -16,807 Closed
SSA
267
Schonfeld Strategic Advisors
New York
– -$1.15M -15,333 Closed
TCM
268
Tributary Capital Management
Nebraska
– -$1.15M -15,300 Closed
Jacobs Levy Equity Management
269
Jacobs Levy Equity Management
New Jersey
– -$937K -12,520 Closed
LP
270
LMR Partners
United Kingdom
– -$835K -11,150 Closed
HF
271
HRT Financial
New York
– -$796K -10,640 Closed
BFM
272
Boothbay Fund Management
New York
– -$795K -10,621 Closed
DLPIC
273
Davide Leone & Partners Investment Company
United Kingdom
– -$795K -10,621 Closed
Connor, Clark & Lunn Investment Management (CC&L)
274
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
– -$793K -10,596 Closed
HS
275
HighVista Strategies
Massachusetts
– -$757K -10,111 Closed
8 9 10
11
12